# Hawaii Senators Advocate for Federal Cannabis Legalization and Expungement

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/federal-cannabis-legalization-hawaii-senators-push/
> **Published:** 2026-04-04T16:20:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:30:40-04:00
> **Clinical Summary:** Hawaii senators push for federal cannabis legalization to improve medical access and clear past convictions, impacting clinical practice and research.

---

✦ New
CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications.
⚒ Cannabis News  |  CED Clinic
PolicyFederal RegulationMedical CannabisHealthcare AccessClinical Practice

Why This Matters

Federal [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) would fundamentally alter clinical practice by enabling interstate research collaboration, standardizing product regulations, and allowing physicians to prescribe rather than recommend cannabis. This policy shift could accelerate evidence generation and improve patient access to consistent, regulated products.

Clinical Summary
Hawaii’s senators are advocating for federal marijuana legalization and expungement of past convictions, joining a growing number of states pushing for comprehensive federal reform. Federal legalization would remove cannabis from Schedule I status, potentially allowing [FDA regulation](https://cedclinic.com/fda-warning-on-cbd-products/) of products and enabling traditional pharmaceutical research pathways. Currently, the state-federal legal disconnect creates clinical and regulatory challenges for healthcare providers and limits research opportunities that could inform evidence-based practice.

Dr. Caplan’s Take

“Federal legalization represents the single most important policy change that could advance [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) from its current evidence-limited state to a truly clinical discipline. Until we have federal clarity, we’re practicing in a regulatory gray zone that serves neither patients nor scientific rigor well.”

Clinical Perspective
🧠 Clinicians should monitor federal policy developments as they directly impact practice scope, research opportunities, and product availability. Federal legalization would likely trigger significant changes in clinical guidelines, insurance coverage, and prescribing protocols. Healthcare systems should begin preparing for potential regulatory shifts while maintaining current compliance with state-level medical cannabis programs.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Hawaii%20Senators%20Push%20Congress%20To%20Federally%20Legalize%20Marijuana%20And%20Clear%20Past%20Con...%20%40drcaplan&url=https%3A//www.marijuanamoment.net/hawaii-senators-push-congress-to-federally-legalize-marijuana-and-clear-past-convictions/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.marijuanamoment.net/hawaii-senators-push-congress-to-federally-legalize-marijuana-and-clear-past-convictions/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Hawaii%20Senators%20Push%20Congress%20To%20Federally%20Legalize%20Marijuana%20And%20Clear%20Past%20Con...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.marijuanamoment.net/hawaii-senators-push-congress-to-federally-legalize-marijuana-and-clear-past-convictions/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.marijuanamoment.net/hawaii-senators-push-congress-to-federally-legalize-marijuana-and-clear-past-convictions/](https://www.marijuanamoment.net/hawaii-senators-push-congress-to-federally-legalize-marijuana-and-clear-past-convictions/)

Table of Contents

- [FAQ](#FAQ)[What type of cannabis policy changes are being discussed?](#What_type_of_cannabis_policy_changes_are_being_discussed)
- [How does this impact healthcare access for patients?](#How_does_this_impact_healthcare_access_for_patients)
- [What is the clinical significance of these regulatory updates?](#What_is_the_clinical_significance_of_these_regulatory_updates)
- [Are these changes at the state or federal level?](#Are_these_changes_at_the_state_or_federal_level)
- [Who should be most concerned about these policy changes?](#Who_should_be_most_concerned_about_these_policy_changes)
- [Related](#Related)

## FAQ

#### What type of cannabis policy changes are being discussed?

The article focuses on federal regulation changes affecting medical cannabis. These policy updates have high clinical relevance and direct implications for healthcare providers and patients.

#### How does this impact healthcare access for patients?

The policy changes are expected to influence healthcare access related to medical [cannabis treatment options](https://cedclinic.com/medical-cannabis-evaluation-right-for-you/). This could affect how patients obtain and use [cannabis-based therapies](https://cedclinic.com/cannabinoids-inhibit-keratinocyte-proliferation-non-cb1-cb2/) under medical supervision.

#### What is the clinical significance of these regulatory updates?

This update receives a high clinical relevance rating (#82), indicating strong evidence or policy relevance with direct clinical implications. Healthcare providers should be aware of these changes for patient care decisions.

#### Are these changes at the state or federal level?

These are federal regulation changes, which means they will have nationwide implications. Federal policy updates typically supersede or influence state-level cannabis regulations.

#### Who should be most concerned about these policy changes?

Healthcare providers, medical cannabis patients, and clinical facilities should pay close attention to these updates. The changes may affect prescribing practices, patient access, and compliance requirements in medical settings.

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Congress Has The Votes To Pass Federal Marijuana Reform, Top House Democrat Says](https://cedclinic.com/federal-marijuana-reform-congressional-support/)

Explore the latest developments as Congress moves closer to passing federal marijuana reform, with strong bipartisan support.

[Read More](https://cedclinic.com/federal-marijuana-reform-congressional-support/)

[Federal move could ease restrictions on medical marijuana – KTLO](https://cedclinic.com/federal-move-medical-marijuana-easing-restrictions/)

Learn how federal policy changes may ease restrictions on medical marijuana, improving patient access and clinical practice.

[Learn More](https://cedclinic.com/federal-move-medical-marijuana-easing-restrictions/)

[Federal cannabis reform has “the votes,” top Dem says (Newsletter: April 22, 2026)](https://cedclinic.com/2026-cannabis-federal-reform-votes-clinical-impact/)

Stay updated with the latest newsletter covering the strong momentum behind federal cannabis reform legislation.

[Subscribe Now](https://cedclinic.com/2026-cannabis-federal-reform-votes-clinical-impact/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
